Reuters - Video

エディション: US | UK | IN | CN | JP

video

Sanofi buys haemophilia specialist for $11.6 bn

2018年 1月 22日 Monday - 01:31

Sanofi has agreed to buy U.S. haemophilia specialist Bioverativ for $11.6 billion. As Silvia Antonioli reports, the French healthcare group says the deal will boost earnings and strengthen its presence in treatments for rare diseases.

▲ ストーリーを隠す

ストーリーを表示する

Sanofi has agreed to buy U.S. haemophilia specialist Bioverativ for $11.6 billion. As Silvia Antonioli reports, the French healthcare group says the deal will boost earnings and strengthen its presence in treatments for rare diseases.

リンクをコピーするには:URL上で右クリック後「コピー」を選択。モバイル端末では、URLを長押ししてください。

Sanofi buys haemophilia specialist for $11.6 bn

2018年 1月 22日 Monday - 01:31